The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), in collaboration with the Center for Drug Evaluation and Research (CDER), are announcing the following public workshop entitled “Model Informed Drug Development Approaches for Immunogenicity Assessments.”
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3dZmJbG
No comments:
Post a Comment